Ying-Yi Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
-
- Epigenetics and DNA Methylation 3
- Wnt/β-catenin signaling in development and cancer 2
- Protein purification and stability 2
-
- Cancer Mechanisms and Therapy 6
- Co-authors
- Chen Liang (4 shared papers)Chifumi Fujii (1 shared paper)Yuichiro Nagai (1 shared paper)Hiroshi Ishikura (1 shared paper)Naofumi Mukaida (2 shared papers)Boryana Konstantinova Popivanova (1 shared paper)Takanori Aoki (1 shared paper)Munirah Ahmad (1 shared paper)
- Journals
- International Journal of Molecular Sciences (4 papers)Cancer Research (2 papers)Viruses (2 papers)The AAPS Journal (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Ying-Yi Li
28 papers receiving 615 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 173
- Pathology and Forensic Medicine 190
- Oncology 263
- Molecular Biology 344
- Immunology and Allergy 27
Countries citing papers authored by Ying-Yi Li
This map shows the geographic impact of Ying-Yi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Yi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Yi Li more than expected).
Fields of papers citing papers by Ying-Yi Li
This network shows the impact of papers produced by Ying-Yi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Yi Li. The network helps show where Ying-Yi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying-Yi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 141 | |
| 2 | 2015 | 89 | |
| 3 | 2004 | 88 | |
| 4 | 2015 | 41 | |
| 5 | 2018 | 39 | |
| 6 | 2015 | 33 | |
| 7 | 2022 | 27 | |
| 8 | 2016 | 25 | |
| 9 | 2014 | 22 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 14 | |
| 12 | 2013 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2022 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2013 | 7 | |
| 17 | [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats]. | 2012 | 7 |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 4 |
About Ying-Yi Li
Ying-Yi Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Cancer Research and Epidemiology, having authored 30 papers that have together received 624 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (6 papers), Hepatitis B Virus Studies (4 papers), Peptidase Inhibition and Analysis (3 papers), Epigenetics and DNA Methylation (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Protein purification and stability (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Cancer Research (173 citations), Pathology and Forensic Medicine (190 citations), Oncology (263 citations), Molecular Biology (344 citations) and Immunology and Allergy (27 citations). Ying-Yi Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Chen Liang, Chifumi Fujii, Yuichiro Nagai, Hiroshi Ishikura, Naofumi Mukaida, Boryana Konstantinova Popivanova, Takanori Aoki, Munirah Ahmad, Hiroshi Sato and Takahisa Takino. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Research, Viruses, The AAPS Journal and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.